Cyclacel Pharmaceuticals Inc (CYCC)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Apr 26, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Max Drawdown (5Y): 99.30% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.30% |
| February 29, 2024 | 99.28% |
| January 31, 2024 | 99.28% |
| December 31, 2023 | 99.11% |
| November 30, 2023 | 99.06% |
| October 31, 2023 | 99.06% |
| September 30, 2023 | 99.06% |
| August 31, 2023 | 99.06% |
| July 31, 2023 | 99.06% |
| June 30, 2023 | 99.06% |
| May 31, 2023 | 99.06% |
| April 30, 2023 | 99.06% |
| March 31, 2023 | 99.06% |
| February 28, 2023 | 99.06% |
| January 31, 2023 | 99.06% |
| December 31, 2022 | 99.06% |
| November 30, 2022 | 99.06% |
| October 31, 2022 | 99.06% |
| September 30, 2022 | 99.06% |
| August 31, 2022 | 99.06% |
| July 31, 2022 | 99.06% |
| June 30, 2022 | 99.06% |
| May 31, 2022 | 99.06% |
| April 30, 2022 | 99.06% |
| March 31, 2022 | 99.06% |
| Date | Value |
|---|---|
| February 28, 2022 | 99.06% |
| January 31, 2022 | 99.06% |
| December 31, 2021 | 99.06% |
| November 30, 2021 | 99.06% |
| October 31, 2021 | 99.06% |
| September 30, 2021 | 99.06% |
| August 31, 2021 | 99.06% |
| July 31, 2021 | 99.06% |
| June 30, 2021 | 99.06% |
| May 31, 2021 | 99.06% |
| April 30, 2021 | 99.06% |
| March 31, 2021 | 99.06% |
| February 28, 2021 | 99.06% |
| January 31, 2021 | 99.06% |
| December 31, 2020 | 99.06% |
| November 30, 2020 | 99.06% |
| October 31, 2020 | 99.06% |
| September 30, 2020 | 99.06% |
| August 31, 2020 | 99.06% |
| July 31, 2020 | 99.06% |
| June 30, 2020 | 99.06% |
| May 31, 2020 | 99.06% |
| April 30, 2020 | 99.06% |
| March 31, 2020 | 99.06% |
| February 29, 2020 | 99.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.82%
Minimum
Apr 2019
99.30%
Maximum
Mar 2024
99.05%
Average
99.06%
Median
Sep 2019
Max Drawdown (5Y) Benchmarks
| Corvus Pharmaceuticals Inc | 95.28% |
| Oragenics Inc | 98.92% |
| Relmada Therapeutics Inc | 95.67% |
| Alpine Immune Sciences Inc | 97.33% |
| MAIA Biotechnology Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -71.40 |
| Beta (5Y) | 0.5372 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 99.15% |
| Historical Sharpe Ratio (5Y) | -0.6494 |
| Historical Sortino (5Y) | -1.356 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.57% |